Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer (Q65402848)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer |
clinical trial |
Statements
Phase II Study of Neratinib in Patients 60 and Older With HER2 Positive Metastatic Breast Cancer (English)
0 references
27 October 2016
0 references
22 October 2019
0 references
40
0 references
60 year
0 references